Inflammatory conditions, i.e., ulcerative colitis (UC) and Crohn’s disease (CD), demonstrate that mTOR activity in IECs is activated by microbial-derived pathogen-associated molecular patterns (PAMPs), thereby exacerbating inflammation [56]. This evidence concerns the gene MTOR and Crohn disease.